Third‑party disclosure: a practical guide for pharmaceutical compliance and risk teams

When internal audits, contractual rights, and voluntary requests fail to produce adequate disclosure, English law provides several routes to unlock critical data quickly and lawfully. This article outlines the principal third-party disclosure mechanisms, when to use them, what to expect in practice, and the common pitfalls for pharmaceutical compliance and